Antibacterial Agents TRIZ Cases

A backbone-cyclized peptide combines with antibiotics to achieve synergistic antimicrobial activity.

Multicomponent staphylococcal vaccine antigens overcome bacterial immune evasion mechanisms to provide effective prevention against S. aureus infections.

Aluminum chelation conjugates 18F to peptides, replacing HPLC purification with filtration to reduce process time.

Str-PAP-1 bacteriophage composition prevents Streptococcus parauberis infections by destroying bacterial cell walls, avoiding antibiotic resistance.

Oral DNase administration overcomes poor absorption barriers, enabling systemic DNA destruction for inflammatory and tumorous conditions.

Cyclic peptidomimetic compounds resolve antibody potency limits by selectively blocking PD-1, PD-L1, or PD-L2 to suppress immunosuppressive signals.

Replacing citric acid with succinic acid prevents chemical degradation of tedizolid phosphate powder for suspension.

A plant fat composition using enzymatically trans-esterified palm oil to reduce transepidermal water loss.

Conditioned plasma from incubated whole blood inhibits bacterial growth without triggering resistance or allergic reactions.

Arylsulfonohydrazide inhibitors target MurC and MurD enzymes, blocking peptidoglycan synthesis to treat antibiotic-resistant bacteria.

Novel MreB inhibitor compounds target essential bacterial proteins to disrupt cell shape maintenance and chromosome segregation.

Modifying thiopeptide structures inhibits EF-Tu activity, treating multidrug-resistant Gram-positive bacteria.

Purified capsule polysaccharide antigens eliminate lipooligosaccharide contaminants, preventing autoimmune responses while maintaining broad serotype coverage.

Shortened finafloxacin regimens eradicate urinary tract pathogens without increasing daily dosages, reducing antibiotic resistance risks.

Engineered DVD proteins use self-sorting domain interfaces to eliminate molecular heterogeneity and reduce immunogenicity in bispecific antibody production.

Phosphonates enable 45-65 wt% alcohol formulations to inactivate poliovirus while reducing flammability and material damage.

Optimized calcium phosphate composition yields moderate hardness for ultrasonic removal without toxic solvents.

Nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compounds target Mycobacterium tuberculosis with potent activity.

Adenosine receptor agonists with pH-dependent affinity target acidic pathological tissues, minimizing hypotension and tachycardia side effects.

CpG rich DNA compositions activate immune responses to treat cancer.

Tamoxifen inhibits Shiga toxin transport by altering endosomal dynamics, resolving the limitation of existing inhibitors that only target STx1.

Engineered peptide linkers in dual variable domain immunoglobulins enable controlled heavy and light chain pairing, reducing molecular heterogeneity.

Peptide p2TA binds bacterial superantigens to block inflammatory cytokine induction, reducing systemic toxicity and mortality in severe infections.

Fermented herbal vaginal capsule inhibits Gardnerella vaginalis and promotes beneficial microbiota to resolve drug resistance and recurrence.

An engineered Fc variant binds the inhibitory FcγRIIb receptor with high affinity to suppress B cell activation signals.

Disulfide-modified polymyxin analogues reduce nephrotoxicity while retaining efficacy against Gram-negative bacterial infections.

Naphthyridine derivatives inhibit MEK and ERK activity to treat hyperproliferative disorders via parameter changes.

Fused tricyclic compounds overcome antibiotic resistance by delivering broad-spectrum efficacy against bacteria, viruses, and fungi.

Liposome-delivered plasmids with CpG motifs trigger immediate innate immunity, resolving the delay in conventional vaccine protection.

A topical composition uses mesenchymal stem cell conditioned medium to reduce somatic cell counts in bovine mastitis treatment.

Substituted tricyclic diproline derivatives induce alpha-helix conformations in peptides and proteins.

A mucoadhesive adjuvant enhances antigen retention on mucosal surfaces to boost immune responses in poultry.

A lasso peptide nanoemulsion formulation combines with antibiotics to enhance antibacterial efficacy.

Compounds targeting GroEL/ES complexes inhibit bacterial protein folding pathways, overcoming antibiotic resistance mechanisms.

DNAzymes cleave resistance gene transcripts, restoring antibiotic susceptibility without increasing human cell toxicity.

Inactivated serotype 5 bacteria administered to sows induce antibodies transferred via colostrum to piglets.

Pyridyltriazole compounds inhibit the B-RAF V600E enzyme to reduce cancer cell proliferation while maintaining solubility.

Modified beta-lactam structures resist enzymatic degradation while maintaining efficacy against Gram-negative pathogens.

Pyrazole pyrimidine compounds inhibit HPK1 with selectivity over IRAK-4, resolving the trade-off between anti-cancer efficacy and side effects.

A three-layer vaginal ring uses crystalline drug cores to enable independent release rate control.

Analyzes peritoneal cellular and humoral markers to differentiate Gram-negative from Gram-positive bacterial infections rapidly.

Novel imidazole heterocyclic compounds inhibit bacterial growth through specific molecular interactions.

Applying a film-forming antiseptic to the nose forms a protective barrier that lowers bacterial counts, preventing bacteremia escalation into septicemia.

Live purified Corynebacterium and Dolosigranulum strains administered intranasally to restore upper respiratory tract microbiome integrity.

Composite RNA nanoparticles with modified nucleotides enhance stability and targeted delivery while minimizing off-target accumulation.

A polyvalent live attenuated bacterial vaccine for cultivated fish uses deletion mutant strains of Vibrio anguillarum to provide cross-immunoprotection.

G-418-based stereoselective pathway eliminates chromatographic separation and hazardous reagents, enabling scalable production.